One of the most promising avenues of research in the quest for new ovarian cancer treatments is the manipulation of the immune system, namely Immunotherapy. The project’s current focus is on various aspects of this type of therapy. Several projects are currently being developed that focus on the immune system as a gateway to better therapies.
Researcher leading the project: Jacques Grill Centre developing the research: The Institute Gustave Roussy, Paris, France Context Tumours of the central nervous system are the second most common form of childhood tumour, after acute leukaemia. However, they are still the leading cause of death in childhood cancer on account of their heterogeneity and the difficulty in treating them effectively.
Principal Investigators: Dr Alberto Ocaña, Dr Atanasio Pandiella Centres: CHUA (University Hospital Complex of Albacete) – Albacete and CIC (Cancer Research Centre) – Salamanca Breast cancer is the most common cancer in the UK. Around 55,200 people are diagnosed with breast cancer every year in the UK. That is around 150 people a day. 15 out of 100 (15%)
CRIS is strongly committed to training medical and research personnel, with the goal of positioning itself as the global vanguard in cancer research and treatment. In 2017, the CRIS Foundation financed 10 research fellowships, lasting between six months and one year, to allow Spanish researchers travel to centres of reference abroad and acquire expertise
Principal Researcher: Dr David Olmos and Dr Elena Castro. Centres: Spanish National Cancer Research Centre (CNIO), IBIMA (Biomedical Research Institute of Malaga). Background: In the UK, about 1 in 8 men will be diagnosed with prostate cancer in their lifetime. Prostate cancer is the most common cancer in men. More than 47,500 men are diagnosed with
Researcher leading the project: Dr. Joaquín Martínez Centres developing the research: 12 de Octubre University Hospital, Madrid, Spanish National Cancer Research Centre (CNIO). Context Haematological, or blood cell tumours represent largely incurable cancers today. Blood cancer is the fifth most common cancer in the UK, with over 40,000 people being diagnosed with it every year. There are about
Investigador Principal: Dr. Enrique de Álava Casado – Dra. Rosa Noguera Salvá Centres: Instituto de Investigaciones Sanitarias INCLIVA and Instituto de Biomedicina de Sevilla (IBiS) (Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla) Introduction: Sarcomas are tumours that arise from cells that make up the connective tissues that support the body. Round-cell sarcomas, in particular, often affect
Name of the Project: Research Project for MLL Leukaemia Principal Investigator: Dr Mireia Camós Centres: Sant Joan de Déu Hospital in Barcelona. Introduction: Paediatric acute leukaemias are the most common form of childhood cancer. Mixed-lineage leukaemia (MLL) in particular is a very aggressive type of leukaemia in children. Although we have seen improvements in the